Dianthus Therapeutics launches $150M underwritten public offering

20 hours ago 1

Healthcare

Comments

Dianthus Therapeutics (NASDAQ:DNTH) has commenced an underwritten public offering of $150M of its shares of its common stock, pre-funded warrants to purchase shares of its common stock.
Dianthus intends to use the net proceeds from this offering to advance the company’s preclinical and clinical development activities, as well as for working capital and general corporate purposes.
DNTH -7.05% after hours to $29.46.
Source: Press Release

More on Dianthus Therapeutics

Recommended For You

More Trending News

Read Entire Article